Skip to main content
RecallsAboutBlog

Drug recalls

Drug recalls from FDA, newest first.
Filters · 1Sort Newest
Agency
Risk level
Date
Sold in

1 recall

Unichem Bisoprolol Fumarate and Hydrochlorothiazide Tablets

Bisoprolol Fumarate and Hydrochlorothiazide tablets fail to meet impurity specification limits.

Moderate risk, FDA, Drug impurity

3 recalls

Akkarco Ashfiat Alharamain Energy Support

Ashfiat Alharamain Energy Support contains undeclared tadalafil, which may pose health risks.

High risk, FDA, Hidden drug ingredient

Greenstone Methylprednisolone Tablets Dosepak

Methylprednisolone tablets have incorrect dosing information on the blister foil.

Moderate risk, FDA, Labeling error

Novadoz Glycopyrrolate Oral Solution

Glycopyrrolate Oral Solution failed impurities and degradation specifications.

Low risk, FDA, Drug impurity

1 recall

Sato INON ACE Antacid Tablets

Failed Disintegration Specifications: above the time expected.

Moderate risk, FDA, Quality testing problem

1 recall

Haleon Parodontax Active Gum Health Mouthwash

Parodontax mouthwash may have missing or illegible lot and expiration date coding on the bottles.

Low risk, FDA, Labeling error

2 recalls

Baxter Sterile Water for Irrigation

Sterile Water for Irrigation contains plastic particles from the bottle rim that can float into the solution.

Moderate risk, FDA, Foreign object

Qunol Extra Strength Turmeric Capsules

Qunol Extra Strength Turmeric Capsules may contain mold contamination.

Moderate risk, FDA, Contamination

1 recall

Zydus Pharmaceuticals Icosapent Ethyl Capsules

Icosapent Ethyl capsules may be subpotent due to oxidation from leakage of capsule contents.

Moderate risk, FDA, Wrong drug strength

2 recalls

Rising Pharmaceuticals Furosemide Tablets

Furosemide Tablets contain a foreign substance.

Moderate risk, FDA, Foreign object

Specialty Process Labs Thyroid USP

Thyroid, USP is subpotent.

Moderate risk, FDA, Wrong drug strength

1 recall

Cipla Diclofenac Sodium Topical Gel 1%

Diclofenac Sodium Topical Gel, 1% failed pH specifications.

Low risk, FDA, Quality testing problem

1 recall

Cipla USA Lanreotide Injection

Lanreotide Injection contains particulate matter.

Moderate risk, FDA, Foreign object

4 recalls

Encon Safety Products Aquarion Preserved Cartridges

The Aquarion Preserved Cartridges have cGMP deviations.

Moderate risk, FDA, Manufacturing problem

Sun Pharmaceutical Clindamycin Phosphate Topical Solution

Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

Low risk, FDA, Drug impurity

Alvogen Levothyroxine Sodium Tablets Thy-Tabs

Levothyroxine Sodium Tablets, USP, Thyro-Tabs may contain 88 mcg tablets instead of 150 mcg tablets.

Moderate risk, FDA, Labeling error

Gold Star Distribution Advil, Aleve, Tylenol and More Over-the-Counter Medicines

Gold Star Distribution medicines have CGMP deviations.

Moderate risk, FDA, Manufacturing problem

1 recall

Taro Pharmaceuticals Fluocinolone Acetonide Topical Solution

Fluocinolone Acetonide Solution Topical Solution failed impurity specifications due to an out-of-specification result for known impurity D.

Low risk, FDA, Drug impurity

1 recall

Herbs Forever Ayurvedic Herbal Supplements

HerbsForever Hingwastik Churna and Gastro Care dietary supplements may contain undeclared wheat, posing a risk of serious allergic reactions.

High risk, FDA, Undeclared wheat

3 recalls

123Herbals Silintan 25 Pills

Silintan capsules contain undeclared meloxicam, which can cause serious life-threatening events.

High risk, FDA, Hidden drug ingredient

SpecGx Oxycodone and Acetaminophen CII Tablets

Oxycodone and Acetaminophen CII Tablets may have a missing imprint on the tablets.

Moderate risk, FDA, Quality testing problem

AvKARE Rosuvastatin Tablets

Rosuvastatin Tablets, USP, 10 mg, are out of specification for dissolution.

Moderate risk, FDA, Drug dissolving problem

1 recall

MediNatura ReBoost and ClearLife Nasal Sprays

ReBoost Nasal Spray and ClearLife Allergy Nasal Spray contain yeast, mold, and microbial contamination.

High risk, FDA, Contamination

2 recalls

Alembic Fesoterodine Fumarate Extended-Release Tablets

Failed impurities/degradation specifications due to levels of 'Diester Impurity' exceeding the specification limit.

Low risk, FDA, Drug impurity

Imprimis NJOF Dexamethasone Moxifloxacin and Tri-Moxi+ Intraocular Injections

Dexamethasone Moxifloxacin intraocular injections contain particulate matter - glass like particles.

Moderate risk, FDA, Foreign object